CTLA4 and autoimmune disease: In both mice and patients treated with CTLA-4 inhibitor, there are decreased circulating Treg and increased T helper (Th) 17 cells, whose enhancement is known to be involved in the pathogenesis of autoimmune diseases [19,20,21].